Loading organizations...
Based in Milan, Italy, Glutensens develops a portable electrochemical biosensor that utilizes artificial intelligence to provide rapid, real-time gluten detection in commercial food products. The company targets the food safety sector by offering its specialized testing devices to restaurants and food manufacturing facilities to prevent cross-contamination for individuals with celiac disease. Currently operating in the seed stage, the enterprise is developing a Detection-as-a-Service business model with full commercialization and international market entry targeted for 2026. To scale its operations, the startup recently raised €1.05 million in seed funding through a financing round backed by institutional investors including Farming Future, CDP Venture Capital, Fondo per l’Imprenditoria Femminile, and ToSeed & Partners. Glutensens was originally founded in 2023 as an official spin-off from the University of Milan by Chiara Di Lorenzo and Andrea Zanella.
Glutensens has raised $1.2M across 1 funding round.
Glutensens has raised $1.2M in total across 1 funding round.
Glutensens has raised $1.2M in total across 1 funding round.
Glutensens's investors include Claudia Pingue, Farming Future, Fondo per l’Imprenditoria Femminile, ToSeed & Partners.
Glutensens has raised $1.2M across 1 funding round. Most recently, it raised $1.2M Seed in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 8, 2025 | $1.2M Seed | Claudia Pingue, Farming Future | Fondo PER L’imprenditoria Femminile, Toseed & Partners | Announced |
